The Japanese Macaque as a Diabetes Recipient Animal Model for Porcine Islet Xenotransplantation

Abstract

Porcine islet xenotransplantation is effective for severe diabetes; however, preclinical studies are essential. In this study, we evaluated the suitability of the Japanese macaque as a recipient model for islet xenotransplantation, including identifying the preferred method to induce diabetes. The safety and stability of the following four models to induce diabetes were assessed: Model 1: pancreatectomy, Model 2: pancreatectomy with low-dose streptozotocin (STZ), Model 3: single-injection of STZ, and Model 4: consecutive administrations of low-dose STZ. Diabetes was induced in all four models. The blood glucose level after induction of diabetes was 225.32 ± 46.49 mg/dL in Model 1, 209.64 ± 64.36 mg/dL in Model 2, 175.51 ± 45.18 mg/dL in Model 3, and 139.22 ± 6.31 mg/dL in Model 4. Regarding safety, Models 1 and 2 involved invasive surgery with postoperative concerns. Model 3 induced diabetes in the Japanese macaques; however, the preferable dose of STZ was individual dependent. Among the models, Model 4 was preferable regarding safety and stability. Finally, we performed porcine islet xenotransplantation in a diabetic monkey in Model 4 and evaluated the therapeutic effects of this treatment. In conclusion, the Japanese macaque might be a possible recipient model for porcine islet xenotransplantation.

Keywords

animal model / diabetes / monkey / pig islet transplantation / xenotransplantation

References

[1] S. Matsumoto and K. Tanaka, “Pancreatic Islet Cell Transplantation Using Non-heart-beating Donors (NHBDs),” Journal of Hepato-Biliary-Pancreatic Surgery 12, no. 3 (2005): 227–230.

[2] T. Anazawa, S. Marubashi, S. Kodama, et al., “Efficacy and Safety of Allogeneic Islet Transplantation Demonstrated by a Multicenter Clinical Trial in Japan,” Transplant Direct 11, no. 3 (2025): e1765.

[3] Y. Nanno, E. Sterner, J. C. Gildersleeve, B. J. Hering, and C. Burlak, “Carbohydrate Antigen Microarray Analysis of Serum IgG and IgM Antibodies Before and After Adult Porcine Islet Xenotransplantation in Cynomolgus Macaques,” PLoS ONE 16, no. 6 (2021): e0253029.

[4] N. Kirchhof, S. Shibata, M. Wijkstrom, et al., “Reversal of Diabetes in Non-immunosuppressed rhesus Macaques by Intraportal Porcine Islet Xenografts Precedes Acute Cellular Rejection,” Xenotransplantation 11, no. 5 (2004): 396–407.

[5] G. W. Byrne, A. M. Azimzadeh, M. Ezzelarab, et al., “Histopathologic Insights Into the Mechanism of Anti-non-Gal Antibody-mediated Pig Cardiac Xenograft Rejection,” Xenotransplantation 20, no. 5 (2013): 292–307.

[6] R. Oriol, Y. Ye, E. Koren, and D. K. Cooper, “Carbohydrate Antigens of Pig Tissues Reacting With human Natural Antibodies as Potential Targets for Hyperacute Vascular Rejection in Pig-to-man Organ Xenotransplantation,” Transplantation 56, no. 6 (1993): 1433–1442.

[7] U. Galili, “Natural Anti-carbohydrate Antibodies Contributing to Evolutionary Survival of Primates in Viral Epidemics?,” Glycobiology 26, no. 11 (2016): 1140–1150.

[8] C. Patience, Y. Takeuchi, and R. A. Weiss, “Infection of human Cells by an Endogenous Retrovirus of Pigs,” Nature Medicine 3, no. 3 (1997): 282–286.

[9] V. Specke, S. Rubant, and J. Denner, “Productive Infection of human Primary Cells and Cell Lines With Porcine Endogenous Retroviruses,” Virology 285, no. 2 (2001): 177–180.

[10] B. P. Griffith, C. E. Goerlich, A. K. Singh, et al., “Genetically Modified Porcine-to-Human Cardiac Xenotransplantation,” New England Journal of Medicine 387, no. 1 (2022): 35–44.

[11] R. A. Montgomery, J. M. Stern, B. E. Lonze, et al., “Results of Two Cases of Pig-to-Human Kidney Xenotransplantation,” New England Journal of Medicine 386, no. 20 (2022): 1889–1898.

[12] H. Hirata, S. Kawai, M. Maeda, et al., “Identification and Phylogenetic Analysis of Japanese Macaque Babesia-1 (JM-1) Detected From a Japanese Macaque (Macaca fuscata fuscata),” American Journal of Tropical Medicine and Hygiene 85, no. 4 (2011): 635–638.

[13] M. L. Graham, S. Ramachandran, A. Singh, et al., “Clinically Available Immunosuppression Averts Rejection but Not Systemic Inflammation After Porcine Islet Xenotransplant in Cynomolgus Macaques,” American Journal of Transplantation 22, no. 3 (2022): 745–760.

[14] R. Bottino, M. F. Knoll, J. Graeme-Wilson, et al., “Safe Use of Anti-CD154 Monoclonal Antibody in Pig Islet Xenotransplantation in Monkeys,” Xenotransplantation 24, no. 1 (2017): e12283.

[15] G. Siddqui, N. Yadav, P. Vishwakarma, et al., “Japanese Encephalitis Virus Induces Vasodilation and Severe Lethality in Adult and Aged AG129 Mice Lacking Alpha, Beta and Gamma Interferon Receptors,” Virus Research 319 (2022): 198884.

[16] N. Sakata, G. Yoshimatsu, R. Kawakami, C. Aoyagi, and S. Kodama, “Optimal Temperature for the Long-term Culture of Adult Porcine Islets for Xenotransplantation,” Frontiers in Immunology 14 (2023): 1280668.

[17] N. Sakata, G. Yoshimatsu, R. Kawakami, K. Chinen, C. Aoyagi, and S. Kodama, “Procedure of Adult Porcine Islet Isolation,” Tissue Eng Part C Methods 29, no. 4 (2023): 144–153.

[18] D. S. Nicol and L. F. Smith, “Amino-acid Sequence of human Insulin,” Nature 187 (1960): 483–485.

[19] A. J. Clark, R. O. Adeniyi-Jones, G. Knight, et al., “Biosynthetic human Insulin in the Treatment of Diabetes. A Double-blind Crossover Trial in Established Diabetic Patients,” Lancet 2, no. 8294 (1982): 354–357.

[20] T. M. Coe, J. F. Markmann, and C. G. Rickert, “Current Status of Porcine Islet Xenotransplantation,” Curr Opin Organ Transplant 25, no. 5 (2020): 449–456.

[21] E. Kemter, J. Denner, and E. Wolf, “Will Genetic Engineering Carry Xenotransplantation of Pig Islets to the Clinic?,” Current Diabetes Reports 18, no. 11 (2018): 103.

[22] R. Zhang, Y. Wang, L. Chen, et al., “Reducing Immunoreactivity of Porcine Bioprosthetic Heart Valves by Genetically-deleting Three Major Glycan Antigens, GGTA1/beta4GalNT2/CMAH,” Acta Biomaterialia 72 (2018): 196–205.

[23] L. Yang, M. Guell, D. Niu, et al., “Genome-wide Inactivation of Porcine Endogenous Retroviruses (PERVs),” Science 350, no. 6264 (2015): 1101–1104.

[24] R. B. Elliott, L. Escobar, O. Garkavenko, et al., “No Evidence of Infection With Porcine Endogenous Retrovirus in Recipients of Encapsulated Porcine Islet Xenografts,” Cell Transplantation 9, no. 6 (2000): 895–901.

[25] S. Matsumoto, P. Tan, J. Baker, et al., “Clinical Porcine Islet Xenotransplantation Under Comprehensive Regulation,” Transplantation Proceedings 46, no. 6 (2014): 1992–1995.

[26] B. J. Hering, M. Wijkstrom, M. L. Graham, et al., “Prolonged Diabetes Reversal After Intraportal Xenotransplantation of Wild-type Porcine Islets in Immunosuppressed Nonhuman Primates,” Nature Medicine 12, no. 3 (2006): 301–303.

[27] Y. Takamura, T. Kajimoto, K. Tanaka, et al., “Internal Organ Dose Rate Conversion Coefficients of Japanese Macaques to 134Cs,137Cs and 131Idagger,” J Radiat Res 64, no. 5 (2023): 804–810.

[28] N. Sakata, G. Yoshimatsu, R. Kawakami, and S. Kodama, “Safe Administration of Immunosuppression in Japanese Monkeys: Relevance to Preclinical Xenotransplantation Studies,” Cell Transplantation 34 (2025): 9636897251322295.

[29] Y. Naganuma, M. Maeda, K. Nakamura, et al., “Impacts of Dosing and Drug Withdrawal Period on Tacrolimus-based Triple Therapy in a Non-human Primate Renal Transplantation Model,” Transplant Immunology 75 (2022): 101704.

[30] Y. Harano, H. Kojima, K. Kosugi, et al., “Hyperlipidemia and Atherosclerosis in Experimental Insulinopenic Diabetic Monkeys,” Diabetes Research and Clinical Practice 16, no. 3 (1992): 163–173.

[31] H. Yasuda, Y. Taniguchi, Z. Huitian, et al., “Chronically Streptozocin-diabetic Monkey Does Not Closely Mimic human Diabetic Neuropathy,” Experimental Neurology 104, no. 2 (1989): 133–137.

[32] H. Mai, C. Liu, B. Fu, et al., “Carnosic Acid Attenuates Diabetic Retinopathy via the SIRT1 Signaling Pathway: Neuroprotection and Endothelial Cell Preservation,” American journal of translational research 17, no. 3 (2025): 2293–2310.

[33] Y. Ji, H. Chen, L. Pang, et al., “AGE Induced Macrophage-derived Exosomes Induce Endothelial Dysfunction in Diabetes via miR-22-5p/FOXP1,” Cardiovasc Diabetol 24, no. 1 (2025): 158.

[34] N. Sakata, G. Yoshimatsu, T. Tanaka, T. Yamada, R. Kawakami, and S. Kodama, “Mechanism of Transplanted Islet Engraftment in Visceral White Adipose Tissue,” Transplantation 104, no. 12 (2020): 2516–2527.

[35] N. Sakata, G. Yoshimatsu, H. Tsuchiya, S. Egawa, and M. Unno, “Animal Models of Diabetes Mellitus for Islet Transplantation,” Exp Diabetes Res 2012 (2012): 256707.

[36] D. J. Leishman, S. H. Oppler, L. L. H. Stone, et al., “Targeted Mapping and Utilization of the Perihepatic Surface for Therapeutic Beta Cell Replacement and Retrieval in Diabetic Non-human Primates,” Front Transplant 3 (2024): 1352777.

[37] G. I. Ellis, K. E. Coker, D. W. Winn, et al., “Trafficking and Persistence of Alloantigen-specific Chimeric Antigen Receptor Regulatory T Cells in Cynomolgus Macaque,” Cell Rep Med 3, no. 5 (2022): 100614.

[38] N. S. Kenyon, M. A. Willman, D. Han, et al., “Extended Survival versus Accelerated Rejection of Nonhuman Primate Islet Allografts: Effect of Mesenchymal Stem Cell Source and Timing,” American Journal of Transplantation 21, no. 11 (2021): 3524–3537.

[39] D. M. Berman, R. D. Molano, C. Fotino, et al., “Bioengineering the Endocrine Pancreas: Intraomental Islet Transplantation within a Biologic Resorbable Scaffold,” Diabetes 65, no. 5 (2016): 1350–1361.

[40] Z. Liu, Y. Lu, W. Hu, et al., “Induction of Diabetes in Cynomolgus Monkey With One Shot of Analytical Grade Streptozotocin,” Animal Model Exp Med 3, no. 1 (2020): 79–86.

[41] T. Oura, K. Hotta, J. Lei, et al., “Immunosuppression with CD40 Costimulatory Blockade plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates,” American Journal of Transplantation 17, no. 3 (2017): 646–656.

[42] T. Oura, K. Hotta, I. Rosales, et al., “Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning with Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism,” Transplantation 103, no. 1 (2019): 168–176.

[43] R. Bottino, M. Wijkstrom, D. J. van der Windt, et al., “Pig-to-monkey Islet Xenotransplantation Using Multi-transgenic Pigs,” American Journal of Transplantation 14, no. 10 (2014): 2275–2287.

[44] S. Nagaraju, S. Bertera, A. Funair, et al., “Streptozotocin-associated Lymphopenia in Cynomolgus Monkeys,” Islets 6, no. 3 (2014): e944441.

[45] H. Zhou, D. J. van der Windt, E. M. Dons, et al., “A Syndrome of Severe Hypoglycemia and Acidosis in Young Immunosuppressed Diabetic Monkeys and Pigs-association With Sepsis,” Transplantation 94, no. 12 (2012): 1187–1191.

[46] G. S. Kim, C. W. Cho, J. H. Lee, et al., “Optimal Allogeneic Islet Dose for Transplantation in Insulin-dependent Diabetic Macaca Fascicularis Monkeys,” Scientific Reports 11, no. 1 (2021): 8617.

[47] G. S. Kim, J. H. Lee, D. Y. Shin, et al., “Integrated Whole Liver Histologic Analysis of the Allogeneic Islet Distribution and Characteristics in a Nonhuman Primate Model,” Scientific Reports 10, no. 1 (2020): 793.

[48] B. J. Oh, S. M. Jin, Y. Hwang, et al., “Highly Angiogenic, Nonthrombogenic Bone Marrow Mononuclear Cell-Derived Spheroids in Intraportal Islet Transplantation,” Diabetes 67, no. 3 (2018): 473–485.

[49] H. Park, J. B. Park, J. H. Kim, et al., “Simultaneous Subtotal Pancreatectomy and Streptozotocin Injection for Diabetes Modeling in Cynomolgus Monkeys,” Transplantation Proceedings 49, no. 5 (2017): 1142–1149.

[50] J. M. Kim, J. S. Shin, B. H. Min, et al., “JAK3 inhibitor-based Immunosuppression in Allogeneic Islet Transplantation in Cynomolgus Monkeys,” Islets 11, no. 5 (2019): 119–128.

[51] M. Watanabe, K. Yamashita, T. Suzuki, et al., “ASKP1240, a Fully human Anti-CD40 Monoclonal Antibody, Prolongs Pancreatic Islet Allograft Survival in Nonhuman Primates,” American Journal of Transplantation 13, no. 8 (2013): 1976–1988.

[52] T. Yoshida, T. Suzuki, M. Watanabe, et al., “Induction of Insulin-dependent Diabetes Mellitus by Total Pancreatectomy for Pancreatic Islet Transplantation in Cynomolgus Monkeys,” J Hepatobiliary Pancreat Sci 19, no. 6 (2012): 661–666.

[53] M. Koulmanda, A. Qipo, Z. Fan, et al., “Prolonged Survival of Allogeneic Islets in Cynomolgus Monkeys After Short-term Triple Therapy,” American Journal of Transplantation 12, no. 5 (2012): 1296–1302.

[54] M. Koulmanda, R. S. Sampathkumar, M. Bhasin, et al., “Prevention of Nonimmunologic Loss of Transplanted Islets in Monkeys,” American Journal of Transplantation 14, no. 7 (2014): 1543–1551.

[55] Y. Li, R. Zheng, L. Jiang, et al., “A Noncoding Variant Confers Pancreatic Differentiation Defect and Contributes to Diabetes Susceptibility by Recruiting RXRA,” Nature Communications 15, no. 1 (2024): 9771.

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.